Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

Made4net, a global provider of cloud-based Warehouse Management Systems (WMS) & end-to-end supply chain execution software, ...

Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

Allegiance Group + Pursuant (AGP), a leading fundraising, marketing, and technology partner for nonprofits, today announced the appointment of Trent Ricker as Chief Executive Officer (CEO).

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

The famous man-eaters likely killed far less people than reported and are no bigger than other lions — although they lack manes, 2004 book notes.

Lilbits: Open Source PebbleOS progress and ARM doesn't plan to terminate Qualcomm's license agreement (for now) ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Reading, writes Edwina Preston, is a way of journeying on the wings of others without moving from the armchair (or bed). Here ...

Dyslexic brain scientist releases LipLetter Land™, a groundbreaking early literacy app for children 3 to 6 years old, and is transforming how young learners build foundational reading skills. Created ...